IP Library › Granted Patent US 12,251,546
Granted Patent B2
US 12,251,546 · App. 18/760,216 · Granted Mar 18, 2025

Medicament delivery device with use indicator

Inventors: Stephan Riedel (Frankfurt am Main, DE); Steffen Raab (Frankfurt am Main, DE); Kerstine Hemmann (Frankfurt am Main, DE); Michael Caspers (Frankfurt am Main, DE); Katja Hoerhold (Frankfurt am Main, DE); Daniel Kerkow (Frankfurt am Main, DE)
Assignee: Sanofi-Aventis Deutschland GMBH
A61M5/5086A61M5/3202A61M2005/3267A61M2205/583A61M2205/584
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,251,546
App. No.
18/760,216
Granted
Mar 18, 2025
Kind
B2
Abstract

Described is a medicament delivery device comprising a case adapted to hold a container with a medicament and having a needle, a needle sleeve telescopically coupled to the case and having a first extended position relative to the case in which the needle is covered, a retracted position relative to the case in which the needle is exposed, and a second extended position relative to the case in which the needle is covered, a first indicia disposed on the needle sleeve which is visible in the first extended position and the second extended position, and a second indicia disposed on the needle sleeve and not visible in the first extended position and visible the second extended position.

Claims (42)

1. A medicament delivery device comprising:

a case adapted to receive a container containing a medicament such that a proximal end of the container is within the case when the container is disposed in case, the container including a needle;

a sleeve movably coupled to the case, the sleeve having a first position relative to the case and a second position relative to the case;

a first indicia disposed on the sleeve, wherein the first indicia is visible when the sleeve is in the first position and the second position, the first indicia comprising a green color; and

a second indicia visible when the sleeve is in the second position, the second indicia comprising a second color different from the green color.

2. The medicament delivery device according to claim 1 , wherein the second indicia is disposed on the sleeve.

3. The medicament delivery device according to claim 1 , wherein the second indicia is axially spaced from the first indicia.

4. The medicament delivery device according to claim 1 , wherein the first indicia comprises a first symbol or a first graphic.

5. The medicament delivery device according to claim 4 , wherein the second indicia comprises a second symbol or a second graphic.

6. The medicament delivery device according to claim 1 , wherein the medicament delivery device is configured to lock the sleeve in the second position.

7. A medicament delivery device comprising:

a case adapted to receive a container containing a medicament, the container including a needle;

a sleeve movably coupled to the case, the sleeve having a first position relative to the case and a second position relative to the case;

a first indicia disposed on the sleeve, wherein the first indicia is visible when the sleeve in the first position and the second position, the first indicia comprising a first color; and

a second indicia visible in the second position, the second indicia comprising a second color different from the first color.

8. The medicament delivery device according to claim 7 , wherein the second indicia is disposed on the sleeve.

9. The medicament delivery device according to claim 7 , comprising a member telescopically movable relative to the case from a proximal position to a distal position.

10. The medicament delivery device according to claim 9 , wherein the member is configured to engage the sleeve.

11. The medicament delivery device according to claim 10 , wherein the medicament delivery device is configured such that the member moves relative to the case when the sleeve moves relative to the case.

12. The medicament delivery device according to claim 10 , wherein the member comprises one or more resilient latches adapted to engage the sleeve.

13. The medicament delivery device according to claim 7 , wherein the first indicia comprises a first symbol or a first graphic.

14. The medicament delivery device according to claim 13 , wherein the second indicia comprises a second symbol or a second graphic.

15. The medicament delivery device according to claim 7 , wherein the first indicia is green.

16. The medicament delivery device according to claim 7 , wherein the second indicia is red.

17. The medicament delivery device according to claim 7 , comprising the container disposed in the case, wherein the medicament comprises a glucagon-like peptide-1 (GLP-1) or an analogue or derivative thereof.

18. An autoinjector comprising:

a case adapted to receive a container containing a medicament such that a proximal end of the container is within the case when the container is disposed in the case, the container including a needle;

a sleeve movably coupled to the case, the sleeve having a first position and a second position relative to the case;

a first indicia disposed on the sleeve, wherein the first indicia is visible when the sleeve is in the first position and the second position, the first indicia comprising a first color; and

a second indicia visible in the second position, the second indicia comprising a second color.

19. The autoinjector according to claim 18 , wherein the second indicia is disposed on the sleeve.

20. The autoinjector according to claim 18 , wherein the first indicia comprises a first symbol or a first graphic.

21. The autoinjector according to claim 20 , wherein the second indicia comprises a second symbol or a second graphic.

22. The autoinjector according to claim 18 , comprising a member telescopically movable relative to the case from a proximal position to a distal position.

23. The autoinjector according to claim 22 , wherein the member is configured to engage the sleeve.

24. The autoinjector according to claim 23 , wherein the autoinjector is configured such that the member moves relative to the case when the sleeve moves relative to the case.

25. The autoinjector according to claim 24 , wherein the member comprises one or more resilient latches adapted to engage the sleeve.

26. The autoinjector according to claim 18 , wherein the autoinjector is configured to lock the sleeve in the second position.

27. The autoinjector according to claim 18 , wherein the first indicia is green.

28. The autoinjector according to claim 27 , wherein the second indicia is red.

29. The autoinjector according to claim 27 , wherein the second indicia is axially spaced from the first indicia.

30. The autoinjector according to claim 18 , comprising the container, wherein the medicament comprises a glucagon-like peptide-1 (GLP-1) or an analogue or derivative thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2024
From: RIEDEL, STEPHAN; RAAB, STEFFEN; HEMMANN, KERSTINE; CASPERS, MICHAEL; HOERHOLD, KATJA; KERKOW, DANIEL
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 068045/0092 →
Priority Claims (1)
EP 12188585 · Oct 15, 2012 · regional
Continuity (5)
Continuation 18662414 · May 13, 2024
Continuation 17000870 · Aug 24, 2020
Continuation 16164774 · Oct 18, 2018
Continuation 14435564
Related Publication 20240350749A1 · Oct 24, 2024
References Cited (54)
US 5591189A · Yoon · 1997 [cited by applicant]
US 7597685B2 · Olson · 2009 [cited by applicant]
US 7918824B2 · Bishop et al. · 2011 [cited by applicant]
US 8409138B2 · James et al. · 2013 [cited by applicant]
US 8734394B2 · Adams et al. · 2014 [cited by applicant]
US 9044553B2 · James et al. · 2015 [cited by applicant]
US 9216256B2 · Olson et al. · 2015 [cited by applicant]
US 9233213B2 · Olson et al. · 2016 [cited by applicant]
US 9402957B2 · Adams et al. · 2016 [cited by applicant]
US 9408976B2 · Olson et al. · 2016 [cited by applicant]
US 9872961B2 · Fourt et al. · 2018 [cited by applicant]
US 10118001B2 · Fourt et al. · 2018 [cited by applicant]
US 10173017B2 · Riedel · 2019 [cited by examiner]
US 10314981B2 · Sampson et al. · 2019 [cited by applicant]
US 10350362B2 · Dennis, Jr. et al. · 2019 [cited by applicant]
US 10363377B2 · Atterbury et al. · 2019 [cited by applicant]
US 10420898B2 · Daniel · 2019 [cited by applicant]
US 10569019B2 · Hirschel et al. · 2020 [cited by applicant]
US 10799647B2 · Hostettler et al. · 2020 [cited by applicant]
US 11298462B2 · Atterbury et al. · 2022 [cited by applicant]
US 11383044B2 · Tschirren et al. · 2022 [cited by applicant]
US 11452821B2 · Lafever et al. · 2022 [cited by applicant]
US 11904153B2 · Riedel et al. · 2024 [cited by applicant]
US 20040039336A1 · Amark et al. · 2004 [cited by applicant]
US 20050101919A1 · Brunnberg · 2005 [cited by applicant]
US 20080269692A1 · James et al. · 2008 [cited by applicant]
US 20090227956A1 · Emmott et al. · 2009 [cited by applicant]
US 20090259178A1 · Brechbuehler et al. · 2009 [cited by applicant]
US 20110066114A1 · McDown et al. · 2011 [cited by applicant]
US 20110288491A1 · Newman et al. · 2011 [cited by applicant]
US 20130041321A1 · Cross · 2013 [cited by examiner]
US 20130211338A1 · Roberts et al. · 2013 [cited by applicant]
US 20180064875A1 · Holmqvist · 2018 [cited by applicant]
US 20190374717A1 · Swanson et al. · 2019 [cited by applicant]
US 20200384213A1 · Riedel et al. · 2020 [cited by applicant]
US 20240350750A1 · Riedel et al. · 2024 [cited by applicant]
US 20240350751A1 · Riedel et al. · 2024 [cited by applicant]
CN 1856333A · 2006 [cited by applicant]
CN 101014379A · 2007 [cited by applicant]
CN 102176937A · 2011 [cited by applicant]
CN 102470219A · 2012 [cited by applicant]
JP 2010501295A · 2010 [cited by applicant]
JP 2011512195A · 2011 [cited by applicant]
WO WO2002047746A1 · 2002 [cited by applicant]
WO WO2009102596A2 · 2009 [cited by applicant]
WO WO2009114777A1 · 2009 [cited by applicant]
WO WO2010136077A1 · 2010 [cited by applicant]
WO WO2011092524A2 · 2011 [cited by applicant]
WO WO2011109205A2 · 2011 [cited by applicant]
WO WO2012000837A1 · 2012 [cited by applicant]
WO WO2019074788A1 · 2019 [cited by applicant]
WO WO2020190529A1 · 2020 [cited by applicant]
International Preliminary Report on Patentability in International Appln. No. PCT/EP2013/070582, dated Apr. 21, 2015, 6 pages. [cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/EP2013/070582, dated Oct. 29, 2013, 8 pages. [cited by applicant]